DaVita (NYSE:DVA) Sets New 1-Year High – Should You Buy?

DaVita Inc. (NYSE:DVA) reached a new 52-week high during trading on Monday . The company traded as high as $236.51 and last traded at $234.7880, with a volume of 830603 shares changing hands. The stock had previously closed at $234.91.

Analysts Set New Price Targets

DVA has been the topic of a number of recent research reports. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. TD Cowen increased their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Barclays raised their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of DaVita in a report on Monday, June 8th. Finally, UBS Group increased their price objective on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, DaVita currently has an average rating of “Hold” and an average price target of $199.17.

DaVita Stock Up 0.8%

The firm has a market cap of $15.21 billion, a PE ratio of 22.01, a price-to-earnings-growth ratio of 0.77 and a beta of 0.88. The business has a 50 day simple moving average of $196.44 and a two-hundred day simple moving average of $156.56.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. During the same period in the prior year, the business posted $2.00 earnings per share. The business’s revenue for the quarter was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Equities analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current year.

Insider Activity at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Kathleen Alyce Waters sold 15,405 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Root Financial Partners LLC lifted its position in shares of DaVita by 128.0% in the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after purchasing an additional 105 shares during the period. Elevation Wealth Partners LLC increased its holdings in DaVita by 147.3% during the fourth quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock valued at $31,000 after buying an additional 165 shares during the period. Caitlin John LLC bought a new position in DaVita in the fourth quarter worth approximately $34,000. Sankala Group LLC purchased a new stake in DaVita during the fourth quarter worth $39,000. Finally, Canada Pension Plan Investment Board purchased a new stake in DaVita during the second quarter worth $43,000. 90.12% of the stock is currently owned by institutional investors.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.